BioSpace News Archive

Fauna Bio, developers of the largest and most accurately characterized hibernation biobank coupled with next-generation sequencing, announced today it has entered into a research collaboration with Novo Nordisk to work towards finding new therapies for obesity by investigating novel molecules and pathways that increase metabolic rate in hibernating mammals

Crestone, Inc. today announced an award from the Cystic Fibrosis Foundation (CFF) for the preclinical development of its antibiotic lead series to treat nontuberculous mycobacteria (NTM) infections, focusing on M. abscessus.

Paragonix Technologies, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Paragonix SherpaPak™ Pancreas Transport System (PTS)1

Casma Therapeutics, Inc., a biotechnology company harnessing the process of autophagy to design powerful new medicines, today announced that Christian Grimm, Ph.D., and Martin Kampmann, Ph.D., will join its scientific advisory board.

Imago BioSciences, Inc. announced that the U.S. Food and Drug Administration has granted Fast Track designation for the development of bomedemstat for the treatment of essential thrombocythemia, a bone marrow disease associated with high platelet counts and potentially catastrophic vascular complications.

Trial will replace currently used chemotherapy conditioning with apamistamab-I-131, Actinium’s targeted conditioning ARC, to selectively eliminate lymphoma cancer cells and stem cells to enable engraftment of stem cell gene therapy

Oncology industry veteran to lead product sales and operations efforts

KalVista Pharmaceuticals, Inc. provided an update on its franchise of oral plasma kallikrein inhibitors for treatment of hereditary angioedema.

CE Mark Approval for EVO Visian ICL Product Family as a Supplemental Lens Offers Unhappy Cataract Patients Opportunity to Achieve Visual Freedom

Daré may be entitled to up to $310 million in commercial milestone payments plus tiered royalties on net sales in the double-digits